Cargando…

Clinical Impact of Beta-blockers in the Revascularization Era

Detalles Bibliográficos
Autor principal:	Kang, Soo-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234848/ https://www.ncbi.nlm.nih.gov/pubmed/32419403 http://dx.doi.org/10.4070/kcj.2020.0112

Ejemplares similares

Cochrane corner: beta-blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2018)

The J Curve Phenomenon is Still Valid in the Era of Primary Revascularization
por: Lee, Hae-Young
Publicado: (2017)

Beta-blockers and the treatment of hypertension: it is time to move on
por: Wiysonge, Charles Shey, et al.
Publicado: (2007)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

Risk Stratification by SYNTAX Score Systems in Current Percutaneous Revascularization Era
por: Kim, Choongki
Publicado: (2019)

Beta-Blockers: A Tale of Triumphs, Trials, and Tribulations
por: Singh, Jagjit
Publicado: (2020)

Beta receptor blocker therapy for the elderly in the COVID-19 era
por: Santillo, Elpidio, et al.
Publicado: (2022)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization
por: Sim, Hui Wen, et al.
Publicado: (2020)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Contrast nephropathy: Risk factors and the role of beta blockers
por: Bowden, Rodney G.
Publicado: (2015)

Beta-blocker therapy in refractory ascites: A steady march towards the truth
por: Bartell, Nicholas, et al.
Publicado: (2022)

A Predictable Propensity : Secondary Revascularization is Associated With Further Revascularization
por: Shishehbor, Mehdi H., et al.
Publicado: (2013)

HEDIS, Beta-Blockers, and What More Can Be Done to Improve Secondary Prevention in ACS
por: Curtiss, Frederic R.
Publicado: (2008)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Does preoperative beta-blocker offer myocardial protection during coronary artery bypass grafting?
por: Rocha, Bruno da Costa
Publicado: (2013)

ACT‐ONE ‐ ACTION at last on cancer cachexia by adapting a novel action beta‐blocker
por: Lainscak, Mitja, et al.
Publicado: (2016)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
por: Lee, Heirim, et al.
Publicado: (2022)

The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon
por: Bartell, Nicholas, et al.
Publicado: (2018)

Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era
por: Hu, Mengjin, et al.
Publicado: (2022)

Impact of Revascularization for Patients Who Survive Life‐Threatening Ventricular Arrhythmias
por: Lindsay, Bruce D.
Publicado: (2014)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

The Optimal Revascularization Therapy for Coronary Artery Disease Patients with Chronic Kidney Disease
por: Park, Chul Soo
Publicado: (2012)

Effects of the beta-blocker carvedilol on arrhythmia and long-term clinical outcomes in benign prostate hypertrophy patients
por: Kim, Soo Jin, et al.
Publicado: (2023)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

Sexual Dysfunction and the Impact of Beta-Blockers in Young Males With Coronary Artery Disease
por: Dai, Yuxiang, et al.
Publicado: (2021)

Exploring the Impact of Prior Beta-Blocker and Calcium Channel Blocker Usage on Clinical Outcomes in Critically Ill Patients With Sepsis: An Observational Study
por: Kumar, Sachin, et al.
Publicado: (2023)

Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently
por: Oomman, Abraham, et al.
Publicado: (2018)

Beta-Blockers in Heart Failure with Preserved Ejection Fraction: Could Their Use Be Vindicated as an Acceptable Option in the Future Treatment Guideline?
por: Cho, Jae Yeong
Publicado: (2019)

Coronary stenting: A matter of revascularization
por: Bonaventura, Aldo, et al.
Publicado: (2017)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Completing the job: The advantage of complete revascularization in ST-elevation myocardial infarction over culprit-only revascularization strategies
por: Moroni, Francesco, et al.
Publicado: (2020)

Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Beta-Blockers and Cancer: Where Are We?
por: Peixoto, Rita, et al.
Publicado: (2020)

Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013)

Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
por: Östman-Smith, Ingegerd
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_htfjgd8s823bq1gpv9bpp996a5